PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate
Clinical trial NCT03900637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03900637
- Sponsor
- Seoul National University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-08
- Primary completion
- 2023-10-31
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.